Novo Nordisk and Eli Lilly shares both fall after Novo’s price-cut plan for Ozempic and Wegovy
Shares of Novo Nordisk and rival Eli Lilly fell on Tuesday after a report said price cuts are coming for…
Shares of Novo Nordisk and rival Eli Lilly fell on Tuesday after a report said price cuts are coming for…
Rafael Henrique | SOPA Images | AP The stock of Hims & Hers fell Friday after a legal threat from…
The US government said it negotiated a 71% discount on Novo Nordisk A/S’s blockbuster Ozempic and Wegovy drugs for patients…
A pill version of Novo Nordisk’s Ozempic failed to slow the progression of Alzheimer’s disease in a pair of trials.…
Novo Nordisk A/S Chief Executive Officer Mike Doustdar may have lost out to Pfizer Inc. in a $10 billion takeover…
Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time…
Novo Nordisk A/S’s latest experimental obesity drug helped patients lose as much as 24.3% of their weight in a small…